Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases

201377 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Pharmacology and Experimental Therapeutics

Volume 345, Issue 2, pp. 260-270

Field-Weighted Citation Impact: 4.92